187 related articles for article (PubMed ID: 12439719)
1. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
[TBL] [Abstract][Full Text] [Related]
2. Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status.
Fritzsche F; Gansukh T; Borgoño CA; Burkhardt M; Pahl S; Mayordomo E; Winzer KJ; Weichert W; Denkert C; Jung K; Stephan C; Dietel M; Diamandis EP; Dahl E; Kristiansen G
Br J Cancer; 2006 Feb; 94(4):540-7. PubMed ID: 16434994
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.
Chang A; Yousef GM; Scorilas A; Grass L; Sismondi P; Ponzone R; Diamandis EP
Br J Cancer; 2002 May; 86(9):1457-64. PubMed ID: 11986781
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
Yousef GM; Fracchioli S; Scorilas A; Borgoño CA; Iskander L; Puopolo M; Massobrio M; Diamandis EP; Katsaros D
Am J Clin Pathol; 2003 Mar; 119(3):346-55. PubMed ID: 12645335
[TBL] [Abstract][Full Text] [Related]
6. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
Yousef GM; Scorilas A; Magklara A; Memari N; Ponzone R; Sismondi P; Biglia N; Abd Ellatif M; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1294-300. PubMed ID: 12439720
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
Yousef GM; Scorilas A; Nakamura T; Ellatif MA; Ponzone R; Biglia N; Maggiorotto F; Roagna R; Sismondi P; Diamandis EP
Breast Cancer Res Treat; 2003 Mar; 78(2):149-58. PubMed ID: 12725415
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
9. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
10. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.
Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues.
Papachristopoulou G; Avgeris M; Charlaftis A; Scorilas A
Thromb Haemost; 2011 Jan; 105(1):131-7. PubMed ID: 21057706
[TBL] [Abstract][Full Text] [Related]
12. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380
[TBL] [Abstract][Full Text] [Related]
13. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.
Hoffman BR; Katsaros D; Scorilas A; Diamandis P; Fracchioli S; Rigault de la Longrais IA; Colgan T; Puopolo M; Giardina G; Massobrio M; Diamandis EP
Br J Cancer; 2002 Sep; 87(7):763-71. PubMed ID: 12232761
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
[TBL] [Abstract][Full Text] [Related]
15. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
Devetzi M; Trangas T; Scorilas A; Xynopoulos D; Talieri M
Thromb Haemost; 2013 Apr; 109(4):716-25. PubMed ID: 23224034
[TBL] [Abstract][Full Text] [Related]
16. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies.
Yousef GM; Magklara A; Chang A; Jung K; Katsaros D; Diamandis EP
Cancer Res; 2001 Apr; 61(8):3425-31. PubMed ID: 11309303
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of human kallikrein 6/protease M expression in ovarian cancer.
Ni X; Zhang W; Huang KC; Wang Y; Ng SK; Mok SC; Berkowitz RS; Ng SW
Br J Cancer; 2004 Aug; 91(4):725-31. PubMed ID: 15305183
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815
[TBL] [Abstract][Full Text] [Related]
19. The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness.
Lose F; Lawrence MG; Srinivasan S; O'Mara T; Marquart L; Chambers S; Gardiner RA; Aitken JF; Spurdle AB; Batra J; Clements JA;
Biol Chem; 2012 Apr; 393(5):403-12. PubMed ID: 22505522
[TBL] [Abstract][Full Text] [Related]
20. High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
Rabien A; Fritzsche F; Jung M; Diamandis EP; Loening SA; Dietel M; Jung K; Stephan C; Kristiansen G
Tumour Biol; 2008; 29(1):1-8. PubMed ID: 18497543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
